# Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke

> **NCT02448641** · PHASE2 · COMPLETED · sponsor: **SanBio, Inc.** · enrollment: 163 (actual)

## Conditions studied

- Chronic Ischemic Stroke

## Interventions

- **BIOLOGICAL:** SB623 Implant (2.5M)
- **BIOLOGICAL:** SB623 Implant (5.0M)
- **PROCEDURE:** Sham surgery

## Key facts

- **NCT ID:** NCT02448641
- **Lead sponsor:** SanBio, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-08
- **Primary completion:** 2018-12-05
- **Final completion:** 2018-12-05
- **Target enrollment:** 163 (ACTUAL)
- **Last updated:** 2020-10-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02448641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02448641, "Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02448641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*